Advances in immunotherapy of gastric cancer / 肿瘤研究与临床

ABSTRACT

Gastric cancer is a common digestive tract tumor derived from the gastric mucosal epithelial cells. Adenocarcinoma is the most common pathological type of gastric cancer, and its treatment is determined by the stage and pathological type. The current treatments of gastric cancer include endoscopic or surgical resection of tumor, chemotherapy and radiotherapy, etc. Although the treatment strategies of gastric cancer have made progress, the efficacy is still not ideal. Immunotherapy has the characteristics of precise effect on tumor microenvironment and long-lasting response, and it has become an important treatment method for various tumors, including gastric cancer.